Zimmer Biomet jumps to highest since April 2025 after raising annual adjusted profit forecast

By Reuters News

** Shares of medical device maker Zimmer Biomet ZBH.N rise 14.9% to $111.56 in afternoon trading, highest since April 2025

** Stock on track for its best one-day performance since November 2020, if gains hold

** Co raises annual adjusted profit forecast to $8.50 to $8.60 per share from prior forecast of $8.47 to $8.59

** ZBH reports Q3 revenue of $2.06 bln versus analysts' estimate of $2.04 bln, according to data compiled by LSEG

** Co reports Q3 adjusted profit of $1.90 per share versus analysts' estimate of $1.88, according to LSEG data

** Including session's move, stock up ~24% YTD

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.